CESSATECH A/S DK -20 (8GN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.025x

Based on the latest financial reports, CESSATECH A/S DK -20 (8GN) has a cash flow conversion efficiency ratio of -0.025x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-300.00K ≈ $-350.73K USD) by net assets (€12.16 Million ≈ $14.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

CESSATECH A/S DK -20 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how CESSATECH A/S DK -20's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does CESSATECH A/S DK -20 carry for a breakdown of total debt and financial obligations.

CESSATECH A/S DK -20 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CESSATECH A/S DK -20 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Respiri Ltd
AU:RSH
-0.863x
Daewoo Elec Co
KO:009320
0.007x
TradeDoubler AB
ST:TRAD
0.041x
Watos Corea Co. Ltd
KQ:079000
0.002x
Live Ventures Inc
NASDAQ:LIVE
0.103x
HyosungONBCo.Ltd
KQ:097870
-0.021x
Kworld Computer Co Ltd
TWO:3287
-0.016x
Integrated Research Ltd
AU:IRI
0.097x

Annual Cash Flow Conversion Efficiency for CESSATECH A/S DK -20 (2021–2025)

The table below shows the annual cash flow conversion efficiency of CESSATECH A/S DK -20 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see 8GN market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €12.16 Million
≈ $14.21 Million
€-17.58 Million
≈ $-20.55 Million
-1.446x -66.04%
2024-12-31 €8.27 Million
≈ $9.67 Million
€-7.21 Million
≈ $-8.43 Million
-0.871x -108.37%
2023-12-31 €-1.92 Million
≈ $-2.24 Million
€-19.97 Million
≈ $-23.35 Million
10.406x +1772.25%
2022-12-31 €23.86 Million
≈ $27.89 Million
€-14.85 Million
≈ $-17.36 Million
-0.622x -61.62%
2021-12-31 €26.24 Million
≈ $30.68 Million
€-10.10 Million
≈ $-11.81 Million
-0.385x --

About CESSATECH A/S DK -20

F:8GN Germany Biotechnology
Market Cap
$46.69 Million
€39.94 Million EUR
Market Cap Rank
#22766 Global
#2003 in Germany
Share Price
€2.15
Change (1 day)
+3.37%
52-Week Range
€1.27 - €3.30
All Time High
€3.47
About

Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-c… Read more